Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

VELPATASVIR for Chronic hepatitis c: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 25 adverse event reports in the FDA FAERS database where VELPATASVIR was used for Chronic hepatitis c.

Most Reported Side Effects for VELPATASVIR

Side Effect Reports % Deaths Hosp.
Fatigue 15 27.8% 4 2
Anaemia 12 22.2% 4 0
Headache 12 22.2% 4 1
Nausea 10 18.5% 2 0
Treatment failure 10 18.5% 0 0
Hepatitis c 9 16.7% 0 0
Pruritus 9 16.7% 1 0
Insomnia 8 14.8% 1 1
Hepatocellular carcinoma 7 13.0% 2 0
Hyperbilirubinaemia 7 13.0% 3 0
Alanine aminotransferase increased 6 11.1% 2 1
Ascites 6 11.1% 2 1
Asthenia 6 11.1% 2 0
Hepatic failure 6 11.1% 3 0
Abdominal pain 5 9.3% 1 1

Other Indications for VELPATASVIR

Hepatitis c (25)

Other Drugs Used for Chronic hepatitis c

RIBAVIRIN (15,707) PEGINTERFERON ALFA-2A (7,898) LEDIPASVIR\SOFOSBUVIR (6,621) SOFOSBUVIR\VELPATASVIR (6,405) SOFOSBUVIR (6,008) TELAPREVIR (3,103) GLECAPREVIR\PIBRENTASVIR (3,072) SIMEPREVIR (2,735) DACLATASVIR (2,063) PEGINTERFERON ALFA-2B (1,927)

Related Pages

VELPATASVIR Full Profile All Chronic hepatitis c Drugs VELPATASVIR Demographics VELPATASVIR Timeline